|1.||Kuwabara, Satoshi: 1 article (11/2015)|
|2.||Kuijf, M L: 1 article (02/2013)|
|3.||Horst-Kreft, D: 1 article (02/2013)|
|4.||Heikema, A P: 1 article (02/2013)|
|5.||Jacobs, B C: 1 article (02/2013)|
|6.||Samsom, J N: 1 article (02/2013)|
|7.||van Wamel, W J B: 1 article (02/2013)|
|8.||Endtz, H P: 1 article (02/2013)|
|9.||Huizinga, R: 1 article (02/2013)|
|10.||Puvanachandra, N: 1 article (01/2012)|
|1.||Miller Fisher Syndrome (Fisher Syndrome)
01/01/2010 - "A clinical diagnosis of Miller Fisher syndrome was reached by anti-ganglioside GQ1B and GM1 Ig G and M antibody investigations which proved positive. "
11/01/2015 - "The lesions in Fisher syndrome and Bickerstaff brainstem encephalitis are presumably determined by the expression of ganglioside GQ1b in the human peripheral and central nervous systems. "
02/01/2013 - "Cross-reactive antibodies to ganglioside GQ1b are strongly associated with oculomotor weakness in GBS and its variant, Miller Fisher syndrome (MFS). "
01/01/2012 - "The suspected diagnosis of Miller-Fisher syndrome was confirmed by the detection of anti-ganglioside GQ1b antibodies."
01/09/2001 - "Miller Fisher syndrome (MFS), a variant of the Guillain-Barré syndrome, is associated with the presence of neuromuscular blocking antibodies, some of which may be directed at the ganglioside GQ1b. "
|2.||Ophthalmoplegia (External Ophthalmoplegia)
01/01/1999 - "That antibody may bind to the paranodal myelin of oculomotor, trochlear and abducens nerves, where GQ1b ganglioside is specifically localized, to cause ophthalmoplegia. "
08/01/1998 - "Serum antibody against ganglioside GQ1b is reported to be closely associated with immune mediated ophthalmoplegia in the Fisher and Guillain-Barré syndromes. "
07/01/1995 - "We showed earlier that sera from BBE patients, as well as from patients with FS and GBS with ophthalmoplegia, have autoantibody to GQ1b ganglioside in the acute phase of the disease. "
08/01/1998 - "Its presence against glycolipids, in particular ganglioside GQ1b, was investigated in patients with ophthalmoplegia of unknown origin. "
01/01/1999 - "IgG antibody against GQ1b ganglioside is specifically raised in sera from patients with Miller Fisher syndrome and Guillain-Barré syndrome with ophthalmoplegia. "
12/01/1992 - "Previously, we reported that ganglioside GQ1b specifically promoted neuritogenesis of human neuroblastoma cells (GOTO), and also that is specifically stimulated the phosphorylation of several cell surface proteins on the same cells. "
10/01/1988 - "A novel, carbohydrate signal-mediated cell surface protein phosphorylation: ganglioside GQ1b stimulates ecto-protein kinase activity on the cell surface of a human neuroblastoma cell line, GOTO."
03/01/1985 - "IV. Ganglioside GQ1b/Ca2+ dependent protein kinase activity exists in the plasma membrane fraction of neuroblastoma cell line, GOTO."
01/01/1984 - "Evidence is presented that a ganglioside, GQ1b, but not other gangliosides examined exhibits a strong biological activity at a few nanomolar concentration for the promotion of neurite outgrowth as well as cell division in two cell lines of neuroblastoma."
01/23/1995 - "The analysis of the neuritogenic activity of GQ1b ganglioside on human neuroblastoma cell lines strongly indicates the possibility that the action is carried out by coupling of GQ1b sugar-specific glycoreceptor of cell surface membrane and a unique, cell surface localized protein kinase (ecto-protein kinase) to phosphorylate cell surface protein(s) with extracellular ATP. "
05/01/1997 - "Cholinergic neuron-specific ganglioside GQ1b alpha a possible target molecule for serum IgM antibodies in some patients with sensory ataxia."
01/01/2009 - "Serum antibodies to the ganglioside GQ1b are associated with immune-mediated ophthalmoplegia and ataxia in patients with Miller-Fisher syndrome (MFS) and Guillain-Barré syndrome. "
05/01/1996 - "In the cranial nerve variant with ophthalmoplegia and ataxia antibodies against the ganglioside GQ1b are found that recognize similar epitopes on specific Campylobacter jejuni strains; for the classical ascending form similar observations are made between anti-GM1 antibodies and C. "
11/01/1994 - "These are; ple21 in limbic encephalitis; PCD17, CDR62, CDR34, and CZF in paraneoplastic cerebellar degeneration; one of the anion transporters band 3 in chorea-acanthocytosis; visinin-like substance in cancer-associated retinopathy (CAR syndrome); myelin basic protein (MBP) and proteolipid protein (PLP) in acute disseminated encephalomyelitis; MBP, PLP and myelin-oligodendrocyte glycoprotein (MOG) in multiple sclerosis; glutamic acid decarboxylase in stiff-man syndrome; GM1 ganglioside in amyotrophic lateral sclerosis; peripheral nerve K+ channel in Isaacs syndrome; synaptotagmin in Lambert-Eaton syndrome; acetylcholine receptor in myasthenia gravis; GM1 ganglioside in Guillain-Barré syndrome; GQ1b ganglioside in Fisher syndrome; myelin-associated glycoprotein in IgM paraproteinemic neuropathy; HuD in paraneoplastic sensory neuropathy; and tRNA and HSP65 in polymyositis."
|1.||Immunoglobulin G (IgG)
|3.||Protein Kinases (Protein Kinase)
|4.||Immunoglobulin M (IgM)
|8.||Myelin-Associated Glycoprotein (S-MAG)
|10.||Transfer RNA (tRNA)